0001562180-21-005810.txt : 20210903 0001562180-21-005810.hdr.sgml : 20210903 20210903161230 ACCESSION NUMBER: 0001562180-21-005810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210901 FILED AS OF DATE: 20210903 DATE AS OF CHANGE: 20210903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hordo Christian CENTRAL INDEX KEY: 0001830070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 211236639 MAIL ADDRESS: STREET 1: C/O SANA BIOTECHNOLOGY, INC. STREET 2: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-09-01 false 0001770121 Sana Biotechnology, Inc. SANA 0001830070 Hordo Christian C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 false true false false EVP, Chief Business Officer Common Stock 2021-09-01 4 M false 1134.00 1.48 A 974934.00 D Common Stock 2021-09-01 4 S false 1134.00 25.0036 D 973800.00 D Common Stock 2021-09-01 4 S false 3002.00 25.0057 D 970798.00 D Stock Option (Right to Buy) 1.48 2021-09-01 4 M false 1134.00 0.00 D 2030-01-26 Common Stock 1134.00 135266.00 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive. This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter. /s/ James J. MacDonald, Attorney-in-Fact for Christian Hordo 2021-09-03